Cardinal Health
7000 Cardinal Place
Dublin
Ohio
43017
United States
Tel: 614-757-5000
Fax: 614-757-6000
Website: http://www.cardinal-health.com/
488 articles with Cardinal Health
-
Cardinal Health Raises Quarterly Dividend - May 10, 2022
5/10/2022
Cardinal Health announced that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus.
-
Cardinal Health Reports Third Quarter Fiscal 2022 Results
5/5/2022
Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2022 revenues of $44.8 billion, an increase of 14% from the third quarter of last year.
-
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2022 on May 5
4/1/2022
Cardinal Health plans to release third-quarter financial results for its fiscal year 2022 on May 5 prior to the opening of trading on the New York Stock Exchange.
-
Teva Pharmaceuticals and AbbVie will pay the state of Rhode Island a combined $28.5 million to settle opioid-related claims against the companies.
-
New Cardinal Health surgical drape helps reduce surgical site contamination risk
3/17/2022
Cardinal Health launched the first surgical incise drape using industry-leading antiseptic Chlorhexidine Gluconate.
-
Cardinal Health Board of Directors Approves Quarterly Dividend - Feb 08, 2022
2/8/2022
Cardinal Health announced that its Board of Directors approved a quarterly dividend of $0.4908 per share.
-
Cardinal Health Reports Second Quarter Fiscal 2022 Results
2/3/2022
Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year.
-
Cardinal Health Provides Medical Segment Fiscal Year 2022 Financial Update
1/10/2022
Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment.
-
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home
1/10/2022
Medically Home announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response and Cardinal Health who will each have representation on the company's Board.
-
Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2022 on February 3
1/3/2022
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange.
-
Modern radiation therapy is tightly targeted to dramatically reduce toxicity and side effects and often can be administered on an outpatient basis.
-
Teva Pharmaceuticals reached a $15 million agreement with the state of Louisiana to settle claims against the company over its marketing of opioid products.
-
Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2022 on November 9
9/27/2021
Cardinal Health plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange.
-
Cardinal Health reports fourth quarter and full year results for fiscal year 2021
8/5/2021
Cardinal Health reported that fourth-quarter fiscal 2021 revenue increased 16% to $42.6 billion.
-
Total payment amounts are contingent on the number of governments that will agree to suspend their lawsuits as part of the deal.
-
Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2021 on August 5
6/24/2021
Cardinal Health plans to release fourth-quarter and year-end financial results for its fiscal year 2021 on August 5 prior to the opening of trading on the New York Stock Exchange.
-
Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK® Pediatric Indication
6/10/2021
Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK ® has been approved for pediatric use by the U.S. Food and Drug Administration (FDA).
-
Cardinal Health and Telix Launch Gallium Awareness Campaign With Release of White-Paper: “Moving Beyond the Myth”
5/27/2021
As interest and demand for more accurate prostate cancer imaging grows, and with the approval of the first Ga-68 PSMA based prostate imaging agent late last year1, Cardinal Health Nuclear & Precision Health Solutions and Telix Pharmaceuticals Inc. have developed an in-depth white-paper, entitled: “Moving beyond the Myth: Meeting the growing demand for Ga-68 radiopharmaceuticals.”
-
Cardinal Health announces redemption of outstanding notes - May 14, 2021
5/14/2021
Cardinal Health announced that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 3.200% notes due June 2022 that are outstanding as of the early redemption date and $262,442,000 in aggregate principal amount of the Company's 2.616% notes due June 2022.
-
Theranos founder Elizabeth Holmes is back in the courtroom for the first time in 15 months for a three-day hearing ahead of her criminal fraud trial.